CD80 and glioma: Furthermore, expression of regulators of mt-rRNA modification was associated with major moieties associated with immune checkpoints in glioma, especially PD-L1, PD-1, CD80, CD274, TIM3, and IDO1 (Supplementary Figure S3B).